Oral Solid Dose

  1. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

  2. USP <922> Water Activity Testing For Oral Solid Dose Pharmaceuticals 8/26/2022

    Gain insight into the technical and regulatory justification for adding water activity measurements into pharmaceutical stability protocols.

  3. Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions 9/10/2024

    Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

  4. Water Activity Is A Critical Parameter For Microbial Stability 10/26/2022

    Learn about USP <1112> Application of Water Activity Determination to Non-sterile Pharmaceutical Products and USP <922> Water Activity, and why water activity is a critical parameter for microbial stability.

  5. Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load 8/13/2024

    Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

  6. Improve The Performance Of Your Small And Large Molecule Medicines 7/23/2024

    Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

  7. Scaling Up A Revolutionary Amorphous Solid Dispersion Platform 3/19/2024

    Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

  8. The Fusion-Based, Solvent-Free Process Disrupting Spray Drying 3/19/2024

    Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

  9. Solvent-Free, Fusion-Based Amorphic Dispersion Process 7/11/2024

    Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).

  10. Technology To Overcome Absorption Hurdles And Solubility Limitations 3/6/2024

    For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.